Doylestown, Pennsylvania Oct 10, 2025 (Issuewire.com) - Korio, Inc. (korioclinical.com), a leading Randomization & Trial Supply Management (RTSM) provider, continues to offer clinical supply consulting services to support sponsors and CROs in building stronger, more reliable RTSM implementations.
Korio has long recognized that successful RTSM goes beyond technology. The company’s consulting service focuses on aligning protocol design, supply strategies, and system configuration—ensuring clinical studies run smoothly from start-up through closeout.
“Our consulting support has always been about reducing risks and building confidence,” said Chuck Harris, Founder & COO, Korio. “By working with sponsors early, we help translate protocol intent into RTSM systems and supply plans that actually work in the real world.”
Sponsors already using Korio’s consulting services report fewer mid-study changes, faster RTSM builds, and stronger site satisfaction. By engaging at the protocol stage, Korio helps teams avoid costly rework and protect patient continuity.
Korio also provides expertise for studies looking to transition away from underperforming RTSM solutions. With proven methodologies, the team supports data migration and operational continuity, minimizing disruption to ongoing trials.
“Clinical supply consulting is not an add-on for us—it’s an essential part of how we partner with clients,” added Harris. “We’re committed to making sure every study is designed to anticipate change and deliver reliable outcomes for patients and sponsors alike.”
About Korio
Korio delivers a next-generation RTSM platform backed by decades of industry expertise. Built for flexibility, quality, and speed, Korio’s solutions provide role-based workflows, robust supply management, and portfolio-level oversight. Together with consulting support, Korio enables sponsors to be Ready for the Trials Ahead™.
For more information, visit korioclinical.com.
Media Contact
Korio *****@korioclinical.com 320 E State Street https://www.korioclinical.com/
